{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T22:10:07Z","timestamp":1697494207106},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":172,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Med Austriaca"],"published-print":{"date-parts":[[2001,7]]},"abstract":"<jats:p><jats:bold>Zusammenfassung: <\/jats:bold> Der Aufschwung der Transplantationsmedizin durch die verbesserte immunsuppressive Therapie hat dazu gef\u00fchrt, dass die Patienten\u2010 und Transplantat\u00fcberlebenszeiten betr\u00e4chtlich zugenommen haben. Mit diesem Erfolg und der zunehmenden Anzahl an Nierentransplantationen steigt aber auch die Rate an Sp\u00e4tkomplikationen, die unter anderem das Skelettsystem betreffen k\u00f6nnen. Der Knochenstoffwechsel vor einer Transplantation weist bereits in vielen F\u00e4llen (pathologische) Ver\u00e4nderungen auf. Bei Patienten mit chronischer dialysepflichtiger Niereninsuffizienz treten in der Regel zwei typische Knochenver\u00e4nderungen auf, einerseits eine \u201eLow\u2010turnover bone disease\u201d, zu der die Osteomalazie und die adyname Knochenkrankheit geh\u00f6ren, oder eine \u201eHigh\u2010turnover bone disease\u201d im Rahmen eines sekund\u00e4ren Hyperparathyroidismus. Viele PatientInnen zeigen Manifestationen beider Erkrankungen (gemischte Osteodystrophie). Vor allem in den ersten Monaten nach der Transplantation ist ein starker Knochenmasseverlust zu beobachten. Einer der daf\u00fcr verantwortlich gemachten Gr\u00fcnde ist die relative starke Immunsuppression in diesen Zeitraum, insbesondere Glukokortikoide scheinen hier eine zentrale Rolle zu spielen. Inwieweit andere Medikamente Einfluss auf den Knochenstoffwechsel haben, ist nicht vollst\u00e4ndig gekl\u00e4rt. Derzeit gibt es kaum Studien \u00fcber eine standardisierte Therapie gegen diesen Knochenabbau, und die Behandlung st\u00fctzt sich vor allem auf Erfahrungen mit anderen Osteoporoseformen.<\/jats:p>","DOI":"10.1046\/j.1563-2571.2001.01019.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T01:52:16Z","timestamp":1047347536000},"page":"81-85","source":"Crossref","is-referenced-by-count":3,"title":["Immunsuppressive Therapie und Knochenstoffwechsel nach Nierentransplantation"],"prefix":"10.1111","volume":"28","author":[{"given":"H.","family":"Koller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708073370603"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223001126"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70064-3"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0221-8747(79)90024-9"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650100119"},{"key":"e_1_2_5_7_2","first-page":"1055","article-title":"Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis","volume":"22","author":"Buckley LM","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650070912"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/014107687807101006","article-title":"Hormonal status in normal, osteoporotic and corticosteroid\u2010treated postmenopausal women","volume":"71","author":"Crilly R","year":"1978","journal-title":"J R Soc Med"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70331-3"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199404270-00016"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712043372301"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02210685"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00890.x"},{"key":"e_1_2_5_15_2","first-page":"50","article-title":"Use of alkaline calcium salts as phosphate binder in uremic patients","volume":"38","author":"Fournier A","year":"1992","journal-title":"Kidney Int"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780240705"},{"key":"e_1_2_5_17_2","first-page":"199","article-title":"Glucocorticoid\u2010induced osteoporosis: pathogenesis, prevention and treatment","volume":"14","author":"Gulko PS","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(99)80005-8"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.323"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507203330307"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197801000-00002"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200009150-00011"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.241"},{"key":"e_1_2_5_24_2","first-page":"3517","article-title":"A study of the toxic effects of cyclosporine on testis and adrenal glands in male rats","volume":"26","author":"Jie Z","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)70118-X"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.5.734"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3914"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511303332201"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90541-3"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.49.11.1099"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-5-352"},{"key":"e_1_2_5_32_2","first-page":"62","article-title":"Risk of adynamic bone disease in dialyzed patients","volume":"38","author":"Malluche HH","year":"1992","journal-title":"Kidney Int"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502023320506"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-5-648"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-5-2571"},{"key":"e_1_2_5_36_2","first-page":"959","article-title":"Prevention of loss of vertebral bone density in heart transplant patients","volume":"11","author":"Muchmore JS","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_5_37_2","first-page":"323","article-title":"Spontaneous fractures following renal transplantations: Clinical and biochemical aspects, bone mineral content and bone morphometry","volume":"2","author":"Nielson HE","year":"1979","journal-title":"Miner Electolyte Meta"},{"key":"e_1_2_5_38_2","first-page":"1764","article-title":"Fracture frequency after kidney transplantation","volume":"26","author":"Nisbeth U","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-6-199509150-00001"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.226"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90138-9"},{"key":"e_1_2_5_42_2","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1001\/archinte.1990.00390230093012","article-title":"Determinants of vertebral mineral density in patients receiving longterm glucocorticoid therapy","volume":"150","author":"Reid IR","year":"1990","journal-title":"Arch Intern Med"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650100513"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/s8756-3282(97)00071-9"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003930070032"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.64"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.73"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.245.9.930"},{"key":"e_1_2_5_49_2","first-page":"489","article-title":"Therapy of osteoporosis: strategies for individualized treatment","volume":"149","author":"Weber K","year":"1999","journal-title":"Wien Med Wochenschr"}],"container-title":["Acta Medica Austriaca"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1563-2571.2001.01019.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1563-2571.2001.01019.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T21:37:05Z","timestamp":1697492225000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1563-2571.2001.01019.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1046\/j.1563-2571.2001.01019.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1563-2571.2001.01019.x","archive":["Portico"],"relation":{},"ISSN":["0303-8173","1563-2571"],"issn-type":[{"value":"0303-8173","type":"print"},{"value":"1563-2571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}